Takeda Pharmaceutical’s (OTCPK:TKPHF) Millennium units is suing Sun Pharmaceuticals Industries (OTCPK:SMPQY), alleging a generic version of its Ninlaro cancer treatment proposed by Sun Pharma infringes on three of its patents.
via Bloomberg.
Takeda seeks a court order to block copies until
its Ninlaro patents expire and to get cash compensation if copies are
made before then, according to a filing in federal court in Wilmington,
DE.
Two patents expire in June 2029 and the other expires in November 2029, according to a supplemental filing.
https://seekingalpha.com/news/3547105-takeda-sues-sun-pharma-to-halt-copies-of-cancer-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.